Form 8.3 - [Abbvie. Inc]
March 26 2020 - 12:02PM
Dow Jones News
TIDM0QCV TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 25(th) March 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 68,083,982 4.61063%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 68,083,982 4.61063%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 62,200 67.80
-------------- ----------------------------- -----------------------
Purchase 5,300 67.91
-------------- ----------------------------- -----------------------
Purchase 500 66.56
-------------- ----------------------------- -----------------------
Purchase 400 67.91
-------------- ----------------------------- -----------------------
Purchase 800 67.91
-------------- ----------------------------- -----------------------
Purchase 500 67.91
-------------- ----------------------------- -----------------------
Purchase 4,622 67.47
-------------- ----------------------------- -----------------------
Purchase 202 66.34
-------------- ----------------------------- -----------------------
Purchase 1,758 67.91
-------------- ----------------------------- -----------------------
Purchase 8,890 67.91
-------------- ----------------------------- -----------------------
Purchase 1,972 67.91
-------------- ----------------------------- -----------------------
Purchase 3,840 67.91
-------------- ----------------------------- -----------------------
Purchase 14,601 67.91
-------------- ----------------------------- -----------------------
Purchase 3,848 67.91
-------------- ----------------------------- -----------------------
Purchase 3,756 67.91
-------------- ----------------------------- -----------------------
Purchase 450 67.91
-------------- ----------------------------- -----------------------
Purchase 14,000 67.91
-------------- ----------------------------- -----------------------
Purchase 15,300 68.33
-------------- ----------------------------- -----------------------
Purchase 200 67.91
-------------- ----------------------------- -----------------------
Purchase 400 67.91
-------------- ----------------------------- -----------------------
Purchase 800 67.91
-------------- ----------------------------- -----------------------
Purchase 706 67.91
-------------- ----------------------------- -----------------------
Purchase 247 67.91
-------------- ----------------------------- -----------------------
Sale 400 67.91
-------------- ----------------------------- -----------------------
Sale 400 67.91
-------------- ----------------------------- -----------------------
Sale 19,800 67.91
-------------- ----------------------------- -----------------------
Sale 197 66.53
-------------- ----------------------------- -----------------------
Sale 131 66.56
-------------- ----------------------------- -----------------------
Sale 4,981 67.91
-------------- ----------------------------- -----------------------
Sale 21,336 67.91
-------------- ----------------------------- -----------------------
Sale 1,986 67.91
-------------- ----------------------------- -----------------------
Sale 400 67.91
-------------- ----------------------------- -----------------------
Sale 182 67.91
-------------- ----------------------------- -----------------------
Sale 500 67.91
-------------- ----------------------------- -----------------------
Sale 200 67.91
-------------- ----------------------------- -----------------------
Sale 534 67.91
-------------- ----------------------------- -----------------------
Sale 116 66.49
-------------- ----------------------------- -----------------------
Sale 306 66.47
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 26(th) March 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
March 26, 2020 11:47 ET (15:47 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Mar 2023 to Mar 2024